RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -58.99 Million USD | 28.72% |
| 2021 | -82.75 Million USD | 8.71% |
| 2020 | -90.65 Million USD | 67.7% |
| 2019 | -280.69 Million USD | -5039.2% |
| 2018 | 5.68 Million USD | -72.83% |
| 2017 | 20.91 Million USD | 1932.85% |
| 2016 | 1.02 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -10.29 Million USD | 58.08% |
| 2023 Q2 | -22.02 Million USD | -113.98% |
| 2022 Q4 | -24.54 Million USD | -76.33% |
| 2022 Q2 | -15.12 Million USD | -180.28% |
| 2022 FY | -58.99 Million USD | 28.72% |
| 2022 Q1 | -5.39 Million USD | 77.94% |
| 2022 Q3 | -13.92 Million USD | 7.95% |
| 2021 Q3 | -25.16 Million USD | 0.0% |
| 2021 FY | -82.75 Million USD | 8.71% |
| 2021 Q4 | -24.45 Million USD | 2.82% |
| 2020 FY | -90.65 Million USD | 67.7% |
| 2019 FY | -280.69 Million USD | -5039.2% |
| 2018 FY | 5.68 Million USD | -72.83% |
| 2017 FY | 20.91 Million USD | 1932.85% |
| 2016 FY | 1.02 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -4317.3% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -1069.396% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -230.532% |
| Nascent Biotech, Inc. | -2.22 Million USD | -2545.435% |
| Rebus Holdings, Inc. | -664 Thousand USD | -8784.036% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 172.069% |
| Qrons Inc. | -643.67 Thousand USD | -9064.534% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -15042.336% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -6.273% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -14098.07% |
| Skye Bioscience, Inc. | -13.67 Million USD | -331.472% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 17.825% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 1300.25% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -22438.838% |
| SQZ Biotechnologies Company | -75.82 Million USD | 22.202% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -1969.456% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -3740.372% |
| Mesoblast Limited | -84.14 Million USD | 29.896% |
| Marizyme, Inc. | -34.08 Million USD | -73.06% |
| Genus plc | 6.4 Million USD | 1021.719% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 705.494% |
| Pharming Group N.V. | -4.87 Million USD | -1108.924% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -2869.576% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -6233.612% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -606.467% |
| ContraFect Corporation | -56.88 Million USD | -3.693% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -1195.138% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -4107.588% |
| IMV Inc. | -38.67 Million USD | -52.541% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -2044.437% |
| MultiCell Technologies, Inc. | -722.81 USD | -8161104.189% |
| ONE Bio Corp. | 13.68 Million USD | 531.165% |
| Accustem Sciences Inc. | -3.74 Million USD | -1474.57% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -12111.683% |
| Q BioMed Inc. | -3.44 Million USD | -1612.031% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 1766.384% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -2145.081% |
| Biomind Labs Inc. | -1 Million USD | -5742.891% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -7.308% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -1933.262% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -787.333% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -3064.072% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -196848.451% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -271.714% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -2952.349% |
| GB Sciences, Inc. | -1.42 Million USD | -4052.737% |
| Alpha Cognition Inc. | -9.7 Million USD | -507.793% |
| HST Global, Inc. | -140.9 Thousand USD | -41764.492% |
| CSL Limited | 3.7 Billion USD | 101.593% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -5143.994% |
| Halberd Corporation | -75.05 Thousand USD | -78500.933% |
| Enzolytics Inc. | -2.14 Million USD | -2645.253% |
| Agentix Corp. | -1.37 Million USD | -4200.327% |
| Resverlogix Corp. | -12.74 Million USD | -362.703% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -1761.897% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 86.122% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -5550.383% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -1920.59% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -3635.069% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -1632.463% |
| AVAX Technologies, Inc. | 6.69 Million USD | 981.384% |
| Zenith Capital Corp. | -8.94 Million USD | -559.622% |
| Genscript Biotech Corporation | -415.79 Million USD | 85.813% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -338514.316% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -2302.541% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -34294.588% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -2842.501% |
| Kadimastem Ltd | -3.04 Million USD | -1840.301% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -5894.596% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -4596.656% |
| BioStem Technologies, Inc. | -7.77 Million USD | -658.327% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -32404.064% |
| LadRx Corporation | -3.82 Million USD | -1442.776% |
| Cell Source, Inc. | -4.32 Million USD | -1263.822% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -8487.233% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -8487.233% |
| NovAccess Global Inc. | -2.46 Million USD | -2291.396% |
| Affymax, Inc. | -15.04 Million USD | -292.064% |
| Itoco Inc. | -919.14 Thousand USD | -6317.956% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -1291.794% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -5171.671% |
| Mobile Lads Corp. | -554.55 Thousand USD | -10537.454% |
| CytoDyn Inc. | -18.05 Million USD | -226.67% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -234266.309% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -26704.133% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -10345.829% |
| SYBLEU INC | -149.18 Thousand USD | -39442.834% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -3147.776% |
| International Stem Cell Corporation | -663 Thousand USD | -8797.436% |
| Bioxytran, Inc. | -3.82 Million USD | -1444.181% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -111963.07% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -289919.666% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -62.659% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -3545.859% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -7916.743% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -1796.175% |
| Neutra Corp. | -229.48 Thousand USD | -25605.272% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -236.336% |
| PureTech Health plc | -146.19 Million USD | 59.651% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -174.485% |
| IXICO plc | -1.43 Million USD | -4005.08% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -521.536% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 51.571% |
| CSL Limited | 3.81 Billion USD | 101.547% |
| Cellectis S.A. | -108.85 Million USD | 45.81% |